Last --
Change Today 0.00 / 0.00%
Volume 0.0
775 On Other Exchanges
775 is not on other exchanges.
All times are local (Market data is delayed by at least 15 minutes).

ck life sciences intl hldgs (775) Snapshot

Previous Close
Day High
Day Low
52 Week High
-- - --
52 Week Low
-- - --
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for CK LIFE SCIENCES INTL HLDGS (775)

Related News

No related news articles were found.

ck life sciences intl hldgs (775) Related Businessweek News

No Related Businessweek News Found

ck life sciences intl hldgs (775) Details

CK Life Sciences Int'l., (Holdings) Inc., an investment holding company, is engaged in the research and development, manufacture, commercialization, marketing, and sale of health and agriculture-related products in the Asia Pacific and North America. It manufactures and markets plant protection products and soluble fertilizers; manufactures, blends, distributes, and sells fertilizers, pesticides, and related agricultural products; manufactures and distributes horticultural products; and contract manufactures complementary healthcare medicines and produces non-sterile prescription and over-the-counter medicines. The company is also involved in licensing registration activities and the importation of finished agricultural goods; holding land and building; financing, water treatment, and trustee activities; investment in financial instruments, as well as vineyards and wineries; trading biotechnology products and nutritional supplements; and the manufacture, wholesale, retail, and distribution of nutraceutical products. In addition, it distributes turf management machinery, hardware, equipment, and accessories, as well as chemicals and professional pest products; produces, refines, and distributes salt products; and provides services in the research and development of bio-technology and life sciences technology products. CK Life Sciences’ products include emulsifiable concentrates, suspension concentrates, aqueous solutions, coated granules, powders, and amination based reactions for crop protection; and pharmaceutical products, such as Tetrodotoxin and POL-103A that are in advanced stages of clinical development, as well as CKBP002 and CKBP004 that are in pre-clinical studies for the treatment of cancer. The company is headquartered in Tai Po, Hong Kong.

1,619 Employees
Last Reported Date: 04/4/14

ck life sciences intl hldgs (775) Top Compensated Officers

Chief Operating Officer, Vice President, Comp...
Total Annual Compensation: $9.1M
Chief Scientific Officer, Vice President and ...
Total Annual Compensation: $6.6M
Compensation as of Fiscal Year 2013.

ck life sciences intl hldgs (775) Key Developments

CK Life Sciences Int'l., (Holdings) Inc. Reports Consolidated Cash Flow Results for the Year Ended December 31, 2013

CK Life Sciences Int'l., (Holdings) Inc. reported consolidated cash flow results for the year ended December 31, 2013. For the year, the company reported net cash from operating activities of HKD 267,056,000 against HKD 435,403,000 a year ago. Purchases of property, plant and equipment was HKD 139,594,000 against HKD 89,181,000 a year ago.

CK Life Sciences Int'l., (Holdings) Inc. Recommends Final Dividend Payable May 30, 2014; Reports Consolidated Earnings Results for the Year Ended December 31, 2013; Proposes Amendments to the Articles of Association

The Board of Directors of CK Life Sciences Int'l., (Holdings) Inc. has recommended a final dividend of HKD 0.007 per share for the year ended 31 December 2013 (HKD 0.006 per share in 2012), a 17% increase over the previous year. The proposed dividend will be paid on 30 May 2014 following approval at the 2014 Annual General Meeting to those shareholders whose names appear on the Register of Members of the company at the close of business on 21 May 2014. The company reported consolidated earnings results for the year ended December 31, 2013. For the period, the company's turnover was HKD 4,970.93 million compared with HKD 4,545.022 million a year ago. Profit before taxation was HKD 303.73 million compared with HKD 301.013 million a year ago. Profit attributable to shareholders of the company was HKD 229.01 million or 2.38 cents per basic and diluted share compared with HKD 176.331 million or 1.83 cents per basic and diluted share a year ago. The company proposed to make certain amendments to the company's articles of association to allow notices of Board meetings to be given to Directors by electronic communication; and to permit electronic signatures on Directors written resolutions and to require all Directors (except those absent from Hong Kong or temporarily unable to act through ill-health or disability) to sign on such resolutions or signify their agreement to them. Further, to align with market practice, the Board proposes to amend the article on rotation of Directors to require not less than one-third of Directors to retire at each annual general meeting of the company and as permitted under the Cayman Islands laws, to give power to the Board to direct on distribution of dividend in specie, at the AGM to be held on May 15, 2014.

CK Life Sciences Int'l., (Holdings) Inc. to Report Fiscal Year 2013 Results on Feb 24, 2014

CK Life Sciences Int'l., (Holdings) Inc. announced that they will report fiscal year 2013 results on Feb 24, 2014


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
775:HK $0.82 HKD 0.00

775 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Hong Kong Jewellery Holding Ltd $0.29 HKD +0.005
Hutchison Harbour Ring Ltd $0.60 HKD 0.00
Real Nutriceutical Group Ltd $1.69 HKD +0.01
Tom Group Ltd $1.37 HKD 0.00
View Industry Companies

Industry Analysis


Industry Average

Valuation 775 Industry Range
Price/Earnings 34.4x
Price/Sales 1.6x
Price/Book 1.6x
Price/Cash Flow 26.3x
TEV/Sales 0.6x

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CK LIFE SCIENCES INTL HLDGS, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at